Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McIntosh

Showing results (341-350 of 395) with videos related to

Pageof 40
Sort By:
Molecular Cancer Therapeutics|December 25, 2019
Monoclonal Antibody Targeting Sialyl-di-Lewis<sup>a</sup>-Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development PotentialSilvana T Tivadar, Richard S McIntosh, Jia Xin Chua, et al.
The Journal of Urology|September 8, 2005
A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressureC J Griffiths, C Harding, C Blake, et al.
Tobacco Control|May 26, 2006
Tobacco use in the Dominican Republic: understanding the culture firstA M Dozier, D J Ossip-Klein, S Diaz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2002
A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cellsFrancis C Lynn, Stephen A Thompson, J Andrew Pospisilik, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
Pain|October 25, 2011
The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of actionGiovanni Martino, Carole Puma, Xiao Hong Yu, et al.
Endocrinology|September 10, 2003
Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinaseJan A Ehses, Vanbric R Casilla, Tim Doty, et al.
Transfusion|April 14, 2019
Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperaturesJoshua L Fenderson, M Adam Meledeo, Matthew J Rendo, et al.
Molecular Biotechnology|June 1, 1995
Rapid optimization of electroporation conditions for plant cells, protoplasts, and pollenJ A Saunders, C H Lin, B H Hou, et al.
The British Journal of Ophthalmology|May 19, 2004
Treatment of Erdheim-Chester disease with cladribine: a rational approachC Myra, L Sloper, P J Tighe, et al.
Pageof 40

Showing results (341-350 of 395) with videos related to

Sort By:
Pageof 40
Molecular Cancer Therapeutics|December 25, 2019
Monoclonal Antibody Targeting Sialyl-di-Lewis<sup>a</sup>-Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development PotentialSilvana T Tivadar, Richard S McIntosh, Jia Xin Chua, et al.
The Journal of Urology|September 8, 2005
A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressureC J Griffiths, C Harding, C Blake, et al.
Tobacco Control|May 26, 2006
Tobacco use in the Dominican Republic: understanding the culture firstA M Dozier, D J Ossip-Klein, S Diaz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2002
A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cellsFrancis C Lynn, Stephen A Thompson, J Andrew Pospisilik, et al.
Prostate Cancer and Prostatic Diseases|February 6, 2013
Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancerK Miller, J W Moul, M Gleave, et al.
Pain|October 25, 2011
The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of actionGiovanni Martino, Carole Puma, Xiao Hong Yu, et al.
Endocrinology|September 10, 2003
Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinaseJan A Ehses, Vanbric R Casilla, Tim Doty, et al.
Transfusion|April 14, 2019
Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperaturesJoshua L Fenderson, M Adam Meledeo, Matthew J Rendo, et al.
Molecular Biotechnology|June 1, 1995
Rapid optimization of electroporation conditions for plant cells, protoplasts, and pollenJ A Saunders, C H Lin, B H Hou, et al.
The British Journal of Ophthalmology|May 19, 2004
Treatment of Erdheim-Chester disease with cladribine: a rational approachC Myra, L Sloper, P J Tighe, et al.
Pageof 40